FDA’s top drug regulator ousted amid agency upheaval
Upheaval among the top ranks of the Food and Drug Administration continued late Friday when Tracey Beth Høeg, the agency’s top drug regulator, was ousted. Høeg had served as acting director of the FDA’s Center for Drug Evaluation and Research (CDER) since December, and was the fi.

Expanded Context
Brimstone Report is tracking this as a curated politics brief. The source report from The Hill says: Upheaval among the top ranks of the Food and Drug Administration continued late Friday when Tracey Beth Høeg, the agency’s top drug regulator, was ousted. Høeg had served as acting director of the FDA’s Center for Drug Evaluation and Research (CDER) since December, and was the fi.
This page is not original reporting. It gives readers the Brimstone view of the story: what is known from the attributed source, why the topic matters, and where to continue reading the original report.
At publication, this brief is anchored to a single attributed source. Readers should treat early details as provisional until additional reporting, official statements, or documents appear.
Why It Matters
Political developments can affect public policy, agencies, budgets, investigations, elections, and the legal process. The value is in tracking what changed and what remains unresolved.
Key Facts
- Primary source: The Hill
- Published: May 18, 2026, 3:31 PM UTC
- Coverage area: Politics
- Brimstone role: curated summary, explanation, and source attribution
- Topic signals: developing story metadata
Timeline
- Source published: May 18, 2026, 3:31 PM UTC
- Brimstone indexed: Added to the curated Brimstone feed and linked to related coverage.
- Next update to watch: Additional sourcing, official confirmation, court or agency records, or follow-up reporting.
Source Attribution
This Brimstone page summarizes and contextualizes a third-party report. Continue to the original publisher for full reporting, documents, quotes, and updates.
Read Original Source

